Video Versus Conversational Contraceptive Counseling During Maternity Hospitalization

Sponsor
Oregon Health and Science University (Other)
Overall Status
Completed
CT.gov ID
NCT03400449
Collaborator
Universidad de Antioquia (Other)
240
2
2
15.3
120
7.8

Study Details

Study Description

Brief Summary

A randomized trial comparing LARC uptake and satisfaction after either video or conversational-based contraceptive counseling for pregnant women in labor.

Condition or Disease Intervention/Treatment Phase
  • Other: Video counseling
  • Other: Conversational counseling
N/A

Detailed Description

This was a multi-center randomized, controlled trial examining contraceptive counseling in the setting of long-acting reversible contraception (LARC) uptake and immediate provision. At two urban public hospitals with large adolescent populations, participants were randomized to a structured, in-person conversation with a trained counselor or a 14-minute video providing the same information. Both participant groups were provided written materials and both had the opportunity to ask questions of the counselor. The total time to complete counseling was measured, as well as participant satisfaction, pre- and post-intervention contraceptive knowledge, and intended postpartum contraceptive method.

Study Design

Study Type:
Interventional
Actual Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two groups randomized to counseling type.Two groups randomized to counseling type.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Video Versus Conversational Contraceptive Counseling During Maternity Hospitalization: The COMSE Randomized Trial
Actual Study Start Date :
Apr 28, 2015
Actual Primary Completion Date :
Aug 7, 2016
Actual Study Completion Date :
Aug 7, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Video counseling

The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end.

Other: Video counseling
Video counseling

Active Comparator: Conversational counseling

The conversation group participated in a structured, face-to-face conversation with a trained counselor.

Other: Conversational counseling
Conversational counseling

Outcome Measures

Primary Outcome Measures

  1. Total Counseling Time [Immediately following the intervention, an average of less than 30 minutes]

    Duration of counseling in minutes (from initiation of counseling to conclusion of all questions answered.) The clock was not stopped for breaks, which were allowed as needed.

Secondary Outcome Measures

  1. Knowledge Scores [One hour]

    Mean total correct answer (score) to 7 multiple-choice contraceptive knowledge questions. Total possible score is 0-7, with 7 representing 100% correct answers. Score measured after completion of the knowledge questionnaire, on average less than one hour, before (pre) and after (post) counseling.

  2. Number of Participants Initiating Postpartum LARC Uptake [Assessed at the time of hospital discharge, on average less than 2 days]

    Number of participants initiating long-acting reversible contraception (LARC - intrauterine device (IUD) or implant) prior to hospital discharge.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Live pregnancy >20 weeks gestation

  • Admission to maternity ward for labor

  • Age >14

Exclusion Criteria:
  • Pain >=8 on Wong-Baker FACES pain scale

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maternidad Rafael Calvo Cartagena Colombia
2 Metrosalud Manrique Medellín Colombia

Sponsors and Collaborators

  • Oregon Health and Science University
  • Universidad de Antioquia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maureen Baldwin, Assistant Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT03400449
Other Study ID Numbers:
  • 11331b
First Posted:
Jan 17, 2018
Last Update Posted:
Nov 13, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Video Counseling Conversational Counseling
Arm/Group Description The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end. Video counseling: Video counseling The conversation group participated in a structured, face-to-face conversation with a trained counselor. Conversational counseling: Conversational counseling
Period Title: Overall Study
STARTED 121 119
COMPLETED 120 119
NOT COMPLETED 1 0

Baseline Characteristics

Arm/Group Title Video Counseling Conversational Counseling Total
Arm/Group Description The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end. Video counseling: Video counseling The conversation group participated in a structured, face-to-face conversation with a trained counselor. Conversational counseling: Conversational counseling Total of all reporting groups
Overall Participants 120 119 239
Age (Count of Participants)
<=18 years
20
16.7%
23
19.3%
43
18%
Between 18 and 65 years
100
83.3%
96
80.7%
196
82%
>=65 years
0
0%
0
0%
0
0%
Sex: Female, Male (Count of Participants)
Female
120
100%
119
100%
239
100%
Male
0
0%
0
0%
0
0%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (participants) [Number]
Colombia
120
100%
119
100%
239
100%

Outcome Measures

1. Primary Outcome
Title Total Counseling Time
Description Duration of counseling in minutes (from initiation of counseling to conclusion of all questions answered.) The clock was not stopped for breaks, which were allowed as needed.
Time Frame Immediately following the intervention, an average of less than 30 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Video Counseling Conversational Counseling
Arm/Group Description The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end. Video counseling: Video counseling The conversation group participated in a structured, face-to-face conversation with a trained counselor. Conversational counseling: Conversational counseling
Measure Participants 120 119
Mean (Standard Deviation) [minutes]
16.8
(4.6)
16.3
(4.6)
2. Secondary Outcome
Title Knowledge Scores
Description Mean total correct answer (score) to 7 multiple-choice contraceptive knowledge questions. Total possible score is 0-7, with 7 representing 100% correct answers. Score measured after completion of the knowledge questionnaire, on average less than one hour, before (pre) and after (post) counseling.
Time Frame One hour

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Conversational Counseling Video Counseling
Arm/Group Description The conversation group participated in a structured, face-to-face conversation with a trained counselor. Conversational counseling: Conversational counseling The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end. Video counseling: Video counseling
Measure Participants 119 120
Pre-counseling
3.1
(1.5)
3.1
(1.5)
Post-counseling
5.3
(1.0)
5.1
(1.2)
3. Secondary Outcome
Title Number of Participants Initiating Postpartum LARC Uptake
Description Number of participants initiating long-acting reversible contraception (LARC - intrauterine device (IUD) or implant) prior to hospital discharge.
Time Frame Assessed at the time of hospital discharge, on average less than 2 days

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Conversational Counseling Video Counseling
Arm/Group Description The conversation group participated in a structured, face-to-face conversation with a trained counselor. Conversational counseling: Conversational counseling The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end. Video counseling: Video counseling
Measure Participants 119 120
Count of Participants [Participants]
46
38.3%
44
37%

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Video Counseling Conversational Counseling
Arm/Group Description The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end. Video counseling: Video counseling The conversation group participated in a structured, face-to-face conversation with a trained counselor. Conversational counseling: Conversational counseling
All Cause Mortality
Video Counseling Conversational Counseling
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/120 (0%) 0/119 (0%)
Serious Adverse Events
Video Counseling Conversational Counseling
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/120 (0%) 0/119 (0%)
Other (Not Including Serious) Adverse Events
Video Counseling Conversational Counseling
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/120 (0%) 0/119 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Ob/Gyn Regulatory Specialist
Organization Oregon Health & Science University
Phone 5034940757
Email mccrimmo@ohsu.edu
Responsible Party:
Maureen Baldwin, Assistant Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT03400449
Other Study ID Numbers:
  • 11331b
First Posted:
Jan 17, 2018
Last Update Posted:
Nov 13, 2019
Last Verified:
Oct 1, 2019